These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 26648449)
1. Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers. Jansen AM; van Wezel T; van den Akker BE; Ventayol Garcia M; Ruano D; Tops CM; Wagner A; Letteboer TG; Gómez-García EB; Devilee P; Wijnen JT; Hes FJ; Morreau H Eur J Hum Genet; 2016 Jul; 24(7):1089-92. PubMed ID: 26648449 [TBL] [Abstract][Full Text] [Related]
2. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. Haraldsdottir S; Hampel H; Tomsic J; Frankel WL; Pearlman R; de la Chapelle A; Pritchard CC Gastroenterology; 2014 Dec; 147(6):1308-1316.e1. PubMed ID: 25194673 [TBL] [Abstract][Full Text] [Related]
3. Targeted next generation sequencing screening of Lynch syndrome in Tunisian population. Ben Sghaier R; Jansen AML; Bdioui A; Van Wezel T; Ksiaa M; Elgolli L; Ben Fatma L; Ben Ahmed S; Azzouz MM; Hellara O; Elghali A; Darbel F; Skandrani K; Mokkni M; Gdissa A; Ltaief R; Saad A; Hmila F; Gribaa M; Morreau H Fam Cancer; 2019 Jul; 18(3):343-348. PubMed ID: 31114938 [TBL] [Abstract][Full Text] [Related]
4. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D. Timmerman S; Van Rompuy AS; Van Gorp T; Vanden Bempt I; Brems H; Van Nieuwenhuysen E; Han SN; Neven P; Victoor J; Laenen A; Vergote I Gynecol Oncol; 2020 Apr; 157(1):245-251. PubMed ID: 31980219 [TBL] [Abstract][Full Text] [Related]
5. Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer. Elsayed FA; Kets CM; Ruano D; van den Akker B; Mensenkamp AR; Schrumpf M; Nielsen M; Wijnen JT; Tops CM; Ligtenberg MJ; Vasen HF; Hes FJ; Morreau H; van Wezel T Eur J Hum Genet; 2015 Aug; 23(8):1080-4. PubMed ID: 25370038 [TBL] [Abstract][Full Text] [Related]
6. Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients. Jansen AM; Geilenkirchen MA; van Wezel T; Jagmohan-Changur SC; Ruano D; van der Klift HM; van den Akker BE; Laros JF; van Galen M; Wagner A; Letteboer TG; Gómez-García EB; Tops CM; Vasen HF; Devilee P; Hes FJ; Morreau H; Wijnen JT PLoS One; 2016; 11(6):e0157381. PubMed ID: 27300758 [TBL] [Abstract][Full Text] [Related]
7. DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer. Church DN; Briggs SE; Palles C; Domingo E; Kearsey SJ; Grimes JM; Gorman M; Martin L; Howarth KM; Hodgson SV; ; Kaur K; Taylor J; Tomlinson IP Hum Mol Genet; 2013 Jul; 22(14):2820-8. PubMed ID: 23528559 [TBL] [Abstract][Full Text] [Related]
8. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers. Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875 [TBL] [Abstract][Full Text] [Related]
9. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer. Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581 [TBL] [Abstract][Full Text] [Related]
10. POLE and POLD1 germline exonuclease domain pathogenic variants, a rare event in colorectal cancer from the Middle East. Siraj AK; Bu R; Iqbal K; Parvathareddy SK; Masoodi T; Siraj N; Al-Rasheed M; Kong Y; Ahmed SO; Al-Obaisi KAS; Victoria IG; Arshad M; Al-Dayel F; Abduljabbar A; Ashari LH; Al-Kuraya KS Mol Genet Genomic Med; 2020 Aug; 8(8):e1368. PubMed ID: 32567205 [TBL] [Abstract][Full Text] [Related]
11. A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome. Walker R; Mahmood K; Joo JE; Clendenning M; Georgeson P; Como J; Joseland S; Preston SG; Antill Y; Austin R; Boussioutas A; Bowman M; Burke J; Campbell A; Daneshvar S; Edwards E; Gleeson M; Goodwin A; Harris MT; Henderson A; Higgins M; Hopper JL; Hutchinson RA; Ip E; Isbister J; Kasem K; Marfan H; Milnes D; Ng A; Nichols C; O'Connell S; Pachter N; Pope BJ; Poplawski N; Ragunathan A; Smyth C; Spigelman A; Storey K; Susman R; Taylor JA; Warwick L; Wilding M; Williams R; Win AK; Walsh MD; Macrae FA; Jenkins MA; Rosty C; Winship IM; Buchanan DD; J Transl Med; 2023 Apr; 21(1):282. PubMed ID: 37101184 [TBL] [Abstract][Full Text] [Related]
12. Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome. Bouvet D; Bodo S; Munier A; Guillerm E; Bertrand R; Colas C; Duval A; Coulet F; Muleris M Gastroenterology; 2019 Aug; 157(2):421-431. PubMed ID: 30998989 [TBL] [Abstract][Full Text] [Related]
13. Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis. Vargas-Parra GM; González-Acosta M; Thompson BA; Gómez C; Fernández A; Dámaso E; Pons T; Morak M; Del Valle J; Iglesias S; Velasco À; Solanes A; Sanjuan X; Padilla N; de la Cruz X; Valencia A; Holinski-Feder E; Brunet J; Feliubadaló L; Lázaro C; Navarro M; Pineda M; Capellá G Int J Cancer; 2017 Oct; 141(7):1365-1380. PubMed ID: 28577310 [TBL] [Abstract][Full Text] [Related]
14. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study. Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011 [TBL] [Abstract][Full Text] [Related]
16. Low frequency of POLD1 and POLE exonuclease domain variants in patients with multiple colorectal polyps. Elsayed FA; Tops CMJ; Nielsen M; Ruano D; Vasen HFA; Morreau H; J Hes F; van Wezel T Mol Genet Genomic Med; 2019 Apr; 7(4):e00603. PubMed ID: 30827058 [TBL] [Abstract][Full Text] [Related]
17. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families. Steinke V; Holzapfel S; Loeffler M; Holinski-Feder E; Morak M; Schackert HK; Görgens H; Pox C; Royer-Pokora B; von Knebel-Doeberitz M; Büttner R; Propping P; Engel C; Int J Cancer; 2014 Jul; 135(1):69-77. PubMed ID: 24493211 [TBL] [Abstract][Full Text] [Related]
18. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population. Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186 [TBL] [Abstract][Full Text] [Related]
19. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors. Mensenkamp AR; Vogelaar IP; van Zelst-Stams WA; Goossens M; Ouchene H; Hendriks-Cornelissen SJ; Kwint MP; Hoogerbrugge N; Nagtegaal ID; Ligtenberg MJ Gastroenterology; 2014 Mar; 146(3):643-646.e8. PubMed ID: 24333619 [TBL] [Abstract][Full Text] [Related]